Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 4Phase 3 4Phase 4 2Phase 2/3 2Phase 1/2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Primary Care 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × OTHER × Darbepoetin alfa × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting
210 enrolled

Primary Care

NCT00283621 2018-11-07

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled
Sarcoma

Sarcoma

NCT00355407 2009-03-13

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Completed
31 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡